Clinical Trial Update: Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

View source ↗

Summary

Stanford University is conducting a clinical trial evaluating novel serum markers to monitor response to anti-cancer therapy. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Neoplasms
• Squamous Cell Carcinoma

Snippet

Sponsor: Stanford University | Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma), Neoplasms | Status: RECRUITING